Mechanism of Action of Anti-Inflammatory Drugs (Q41750053)

8 October 2017

1 reference

title

Mechanism of action of anti-inflammatory drugs (English)

1 reference

8 October 2017

Mechanism of Action of Anti-Inflammatory Drugs (English)

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-1810-9_27

19 December 2024

1

J R Vane

1 reference

8 October 2017

J. R. Vane

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9561120

19 December 2024

R. M. Botting

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9561120

19 December 2024

language of work or name

English

0 references

publication date

1 January 1997

1 reference

8 October 2017

1997

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9561120

full work available at URL

19 December 2024

http://link.springer.com/content/pdf/10.1007/978-1-4899-1810-9_27

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-1810-9_27

Advances in Experimental Medicine and Biology

19 December 2024

published in

1 reference

8 October 2017

volume

433

1 reference

8 October 2017

page(s)

131-138

1 reference

The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1

8 October 2017

cites work

3

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-1810-9_27

Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2

19 December 2024

4

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-1810-9_27

A single amino acid difference between cyclooxygenase-1 (COX-1) and -2 (COX-2) reverses the selectivity of COX-2 specific inhibitors.

19 December 2024

5

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-1810-9_27

An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation

19 December 2024

6

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-1810-9_27

Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa

19 December 2024

7

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-1810-9_27

Temporal and pharmacological division of fibroblast cyclooxygenase expression into transcriptional and translational phases

19 December 2024

9

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-1810-9_27

Selective regulation of cellular cyclooxygenase by dexamethasone and endotoxin in mice

19 December 2024

11

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-1810-9_27

Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing

19 December 2024

12

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-1810-9_27

Prostaglandin endoperoxide synthase: regulation of enzyme expression

19 December 2024

15

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-1810-9_27

Aspirin inhibits interleukin 1-induced prostaglandin H synthase expression in cultured endothelial cells

19 December 2024

16

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-1810-9_27

Characterization of Prostaglandin G/H Synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts

19 December 2024

17

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-1810-9_27

Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration.

19 December 2024

18

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-1810-9_27

Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect

19 December 2024

19

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-1810-9_27

Cyclooxygenase-1 and cyclooxygenase-2 gene expression in human colorectal adenocarcinomas and in azoxymethane induced colonic tumours in rats

19 December 2024

20

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-1810-9_27

Aspirin use and reduced risk of fatal colon cancer

19 December 2024

21

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-1810-9_27

Schweizerische medizinische Wochenschrift

19 December 2024

22

126

801

GD Luk

1996

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-1810-9_27

Tissue prostaglandin levels in familial adenomatous polyposis patients treated with sulindac

19 December 2024

23

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-1810-9_27

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

19 December 2024

24

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-1810-9_27

Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction

19 December 2024

25

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-1810-9_27

Effect of cyclic AMP and prostaglandin E2 on the induction of nitric oxide- and prostanoid-forming pathways in cultured rat mesangial cells

19 December 2024

26

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-1810-9_27

Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse.

19 December 2024

27

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-1810-9_27

Risk of upper gastrointestinal bleeding and perforation associated with Individual non-steroidal anti-inflammatory drugs

19 December 2024

28

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-1810-9_27

Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs

19 December 2024

29

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-1810-9_27

Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis

19 December 2024

30

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-1810-9_27

New insights into the mode of action of anti-inflammatory drugs

19 December 2024

31

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-1810-9_27

Inhibition of constitutive and inducible cyclooxygenase activity in human platelets and mononuclear cells by NSAIDS and Cox 2 inhibitors

19 December 2024

32

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-1810-9_27

Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase

19 December 2024

33

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-1810-9_27

19 December 2024

37

32

1

X Rabasseda

1996

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-1810-9_27

Etodolac selectively inhibits human prostaglandin G/H synthase 2 (PGHS-2) versus human PGHS-1

19 December 2024

38

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-1810-9_27

A randomized double-blind comparison of placebo, etodolac, and naproxen on gastrointestinal injury and prostaglandin production

19 December 2024

39

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-1810-9_27

American Family Physician

19 December 2024

40

49

1197

DM Cummings

1994

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-1810-9_27

COX-2 inhibitors at the 8th International Conference of the Inflammation Research Association

19 December 2024

42

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-1810-9_27

19 December 2024

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9561120

19 December 2024

1 reference